CSIMarket Company Name, Ticker, Competitors, else..
 
Stereotaxis Inc   (NYSEAMER: STXS)
Other Ticker:  
 
 
Price: $2.1900 $-0.02 -0.905%
Day's High: $2.24 Week Perf: 5.29 %
Day's Low: $ 2.17 30 Day Perf: -6.81 %
Volume (M): 146 52 Wk High: $ 3.29
Volume (M$): $ 320 52 Wk Avg: $2.19
Open: $2.19 52 Wk Low: $1.66



 Market Capitalization (Millions $) 188
 Shares Outstanding (Millions) 86
 Employees 140
 Revenues (TTM) (Millions $) 24
 Net Income (TTM) (Millions $) -22
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Stereotaxis Inc
Stereotaxis Inc. is a medical technology company that specializes in the field of robotic cardiac ablation. The company designs and manufactures systems that use robotic control and navigation technologies for the treatment of cardiac arrhythmias. The Stereotaxis Robotic Magnetic Navigation System allows physicians to remotely navigate and position catheters within the heart using powerful magnets and precise robotic control, providing greater precision and safety during procedures. Stereotaxis Inc. aims to improve patient outcomes and enhance the efficiency of cardiac procedures through their innovative technologies.


   Company Address: 710 North Tucker Boulevard St. Louis 63101 MO
   Company Phone Number: 678-6100   Stock Exchange / Ticker: NYSEAMER STXS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ATRC      % 
BSX      % 
ELMD      % 
INGN      % 
MDT      % 
RMD      % 
• View Complete Report
   



Product Service News

Hospital da Luz Pioneers Robotic Surgery in Portugal with Genesis Robotic System

Published Wed, Nov 20 2024 1:18 PM UTC

In a groundbreaking advancement for the field of surgical robotics in Portugal, Hospital da Luz in Lisbon has successfully adopted the Genesis Robotic Magnetic Navigation (RMN) System developed by Stereotaxis, a renowned leader in the realm of minimally invasive endovascular interventions. This landmark achievement marks a significant milestone for both the hospital and the ...
Product Service News

University of Kansas Medical Center Bolsters Heart Care with Advanced Robotic Technology

Published Wed, Nov 6 2024 1:25 PM UTC

In a groundbreaking advancement for cardiac medicine, the University of Kansas Medical Center has successfully integrated the cutting-edge Genesis Robotic Magnetic Navigation (RMN) System, a pioneering technology from Stereotaxis, into its heart care program. This monumental step was marked by the successful treatment of its first patients using this state-of-the-art robotic...
Product Service News

Stereotaxis Advances Cardiac Technology with Regulatory Submissions and Hospital Adoption

Published Mon, Aug 12 2024 8:03 PM UTC

Stereotaxis Inc., a leading player in the field of surgical robotics, has recently made significant strides in advancing its cardiac care technology. The company announced the achievement of a CE mark in Europe and the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for its innovative semi-mobile robotic system, GenesisX. This regulatory pro...
Product Service News

Revamping Cardiac Care: Southern Italy's Santa Maria della Piet? Introduces Pioneering Robotic Technology for Heart Rhythm Treatment

Published Wed, May 22 2024 12:42 PM UTC

In a groundbreaking development, the Hospital Santa Maria della Piet?, located in Nola in the Metropolitan City of Naples, has launched Southern Italy s first-ever robotic cardiac heart program. This state-of-the-art technology marks a significant milestone in the region s medical history, promising advanced and precise treatment options for heart rhythm patients.Robotic Car...
Merger and Acquisition

Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies, Paving the Way for Revolutionary Surgical Robotics Transformations.

Published Mon, May 13 2024 8:02 PM UTC

Stereotaxis to Acquire Access Point Technologies in Revolutionary Move towards Surgical Robotics Advancements
ST. LOUIS, May 13, 2024 - Stereotaxis (NYSE: STXS), a renowned pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, has recently announced a game-changing definitive share purchase agreement. Under this agreement, Stere...






Stereotaxis Inc's Segments
Systems    48.26 % of total Revenue
Disposables Service and Accessories    52.81 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com